Mobius Therapeutics, a St. Louis-based developer of systems for the surgical treatment of glaucoma, has raised $3.5 million in first-round funding, according to a regulatory filing. No investor information was disclosed. www.mobiustherapeutics
Mobius Therapeutics, a St. Louis-based developer of systems for the surgical treatment of glaucoma, has raised $3.5 million in first-round funding, according to a regulatory filing. No investor information was disclosed. www.mobiustherapeutics
Copyright PEI Media
Not for publication, email or dissemination